Cigarette smoking remains as a major preventable cause of morbidity and mortality around
the world. Smoking causes many diseases and use of tobacco products is known to have …

The special issue on Biomarkers of Nicotine and Tobacco Dependence reviews the science
for precision treatment of nicotine dependence and future opportunities for research on …

The devastating consequences of tobacco smoking for individuals and societies motivate
studies to identify and understand the biological pathways that drive smoking behaviors, so …

Tobacco smoking is a major determinant of preventable morbidity and mortality worldwide.
More than a billion people smoke, and without major increases in cessation, at least half will …

Genomic medicine can enhance prevention and treatment. First, we propose that advances
in genomics have the potential to enhance assessment of disease risk, improve prognostic …

One way to enhance therapeutic development is through the identification and development
of evaluative tools such as biomarkers. This review focuses on putative diagnostic …

The use of standard protocols in studies supports consistent data collection, improves data
quality, and facilitates cross-study analyses. Funded by the National Institutes of Health, the …

Background Globally, tobacco use causes approximately 6 million deaths per year, and
predictions report that with current trends; more than 8 million deaths are expected annually …

Introduction By improving our understanding of the neurobiological mechanisms underlying
addiction, neuroimaging research is helping to identify new targets for personalized …

abstract Diseases associated with nicotine dependence in the form of habitual tobacco use
are a major cause of premature death in the United States. The majority of tobacco smokers …